SCRI-E2CAR_EGFRtv1 / Seattle Children’s Therapeutics  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SCRI-E2CAR_EGFRtv1 / Seattle Children’s Therapeutics
ENLIGHTen-01, NCT05312411: A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma

Recruiting
1
21
US
SCRI-E2CAR_EGFRtv1, UB_TT170
Seattle Children's Hospital, Umoja BioPharma, Inc.
Osteosarcoma
04/25
04/40

Download Options